These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
182 related articles for article (PubMed ID: 16974068)
1. The novel Src kinase inhibitor M475271 inhibits VEGF-induced vascular endothelial-cadherin and beta-catenin phosphorylation but increases their association. Ali N; Yoshizumi M; Yano S; Sone S; Ohnishi H; Ishizawa K; Kanematsu Y; Tsuchiya K; Tamaki T J Pharmacol Sci; 2006 Sep; 102(1):112-20. PubMed ID: 16974068 [TBL] [Abstract][Full Text] [Related]
2. A novel Src kinase inhibitor, M475271, inhibits VEGF-induced human umbilical vein endothelial cell proliferation and migration. Ali N; Yoshizumi M; Fujita Y; Izawa Y; Kanematsu Y; Ishizawa K; Tsuchiya K; Yano S; Sone S; Tamaki T J Pharmacol Sci; 2005 Jun; 98(2):130-41. PubMed ID: 15937404 [TBL] [Abstract][Full Text] [Related]
3. Inhibition of vascular endothelial growth factor-induced angiogenesis by resveratrol through interruption of Src-dependent vascular endothelial cadherin tyrosine phosphorylation. Lin MT; Yen ML; Lin CY; Kuo ML Mol Pharmacol; 2003 Nov; 64(5):1029-36. PubMed ID: 14573751 [TBL] [Abstract][Full Text] [Related]
4. Dynamics of vascular endothelial-cadherin and beta-catenin localization by vascular endothelial growth factor-induced angiogenesis in human umbilical vein cells. Wright TJ; Leach L; Shaw PE; Jones P Exp Cell Res; 2002 Nov; 280(2):159-68. PubMed ID: 12413882 [TBL] [Abstract][Full Text] [Related]
5. SRC tyrosine kinase inhibitor, m475271, suppresses subcutaneous growth and production of lung metastasis via inhibition of proliferation, invasion, and vascularization of human lung adenocarcinoma cells. Zheng R; Yano S; Matsumori Y; Nakataki E; Muguruma H; Yoshizumi M; Sone S Clin Exp Metastasis; 2005; 22(3):195-204. PubMed ID: 16158247 [TBL] [Abstract][Full Text] [Related]
6. IQGAP1 mediates VE-cadherin-based cell-cell contacts and VEGF signaling at adherence junctions linked to angiogenesis. Yamaoka-Tojo M; Tojo T; Kim HW; Hilenski L; Patrushev NA; Zhang L; Fukai T; Ushio-Fukai M Arterioscler Thromb Vasc Biol; 2006 Sep; 26(9):1991-7. PubMed ID: 16763158 [TBL] [Abstract][Full Text] [Related]
7. ICAM-1-mediated, Src- and Pyk2-dependent vascular endothelial cadherin tyrosine phosphorylation is required for leukocyte transendothelial migration. Allingham MJ; van Buul JD; Burridge K J Immunol; 2007 Sep; 179(6):4053-64. PubMed ID: 17785844 [TBL] [Abstract][Full Text] [Related]
8. Src kinase phosphorylates vascular endothelial-cadherin in response to vascular endothelial growth factor: identification of tyrosine 685 as the unique target site. Wallez Y; Cand F; Cruzalegui F; Wernstedt C; Souchelnytskyi S; Vilgrain I; Huber P Oncogene; 2007 Feb; 26(7):1067-77. PubMed ID: 16909109 [TBL] [Abstract][Full Text] [Related]
9. Carvedilol may attenuate liver cirrhosis by inhibiting angiogenesis through the VEGF-Src-ERK signaling pathway. Ding Q; Tian XG; Li Y; Wang QZ; Zhang CQ World J Gastroenterol; 2015 Aug; 21(32):9566-76. PubMed ID: 26327764 [TBL] [Abstract][Full Text] [Related]
10. VEGF-induced vascular permeability is mediated by FAK. Chen XL; Nam JO; Jean C; Lawson C; Walsh CT; Goka E; Lim ST; Tomar A; Tancioni I; Uryu S; Guan JL; Acevedo LM; Weis SM; Cheresh DA; Schlaepfer DD Dev Cell; 2012 Jan; 22(1):146-57. PubMed ID: 22264731 [TBL] [Abstract][Full Text] [Related]
11. Green tea catechins inhibit VEGF-induced angiogenesis in vitro through suppression of VE-cadherin phosphorylation and inactivation of Akt molecule. Tang FY; Nguyen N; Meydani M Int J Cancer; 2003 Oct; 106(6):871-8. PubMed ID: 12918064 [TBL] [Abstract][Full Text] [Related]
12. Capsiate, a nonpungent capsaicin-like compound, inhibits angiogenesis and vascular permeability via a direct inhibition of Src kinase activity. Pyun BJ; Choi S; Lee Y; Kim TW; Min JK; Kim Y; Kim BD; Kim JH; Kim TY; Kim YM; Kwon YG Cancer Res; 2008 Jan; 68(1):227-35. PubMed ID: 18172315 [TBL] [Abstract][Full Text] [Related]